- Vitana Pediatric & Orthodontic Partners adds Florida practice
- Indiana system opens $21.7M outpatient center
- Trump administration targets medical school admissions: 4 notes
- EyeSouth Partners continues 2026 expansion with Louisiana practice
- RSV lingers in parts of US even as flu and COVID-19 recede
- Seattle Children’s surgeon-in-chief on turning uncertainty into a strategic advantage
- Providence narrows operating loss to $486M in 2025
- Providence narrows operating loss to $486M in 2025
- Florida health system selects Meditech EHR
- A huge month for CMS policy
- What the Health? From KFF Health News: A Headless CDC
- GI is exploding with new tech—but how do patients feel about it?
- HHS, CMS form healthcare advisory committee
- NewYork-Presbyterian named in antitrust lawsuit
- Maryland physician to pay $500K+ to settle false claims allegations
- FirstHealth breaks ground on $43M replacement hospital
- Rhode Island oral surgeon launches Congressional campaign
- Johns Hopkins affiliate names new CEO
- 6 things to know about the pharmacy technician workforce
- Premier Anesthesia, City of Hope Phoenix ink partnership
- 20 behavioral health leaders challenge industry assumptions
- What simulation training revealed about GI skills gaps
- Judge dismisses physician’s wrongful termination suit against staffing firm
- 3 California behavioral health centers to close amid funding shifts
- North Carolina practice to close after 40+ years
- St. Tammany opens outpatient cardiology center
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- 6 dental practice openings to know
- APRNs, PAs account for most antipsychotic prescriptions for Medicare Part D: Study
- Oklahoma House passes bill expanding scope of dental assistants
- Dr. Nellie Kim-Weroha joins American Association of Orthodontists’ Board of Trustees
- California behavioral health agency to close 2 centers
- St. Luke’s CFO joins RCM company’s advisory board
- 52 DSOs to know: 2026
- 10 hospitals, health systems looking for CFOs
- 10 health system rating downgrades
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- North Star’s restructuring moves forward
- Illinois hospital pauses patient care amid payroll challenges
- What the Best-Performing Revenue Cycles Have in Common
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- California peer-run behavioral health center to close amid funding shift
- Remarks at the Financial Stability Oversight Council Meeting
- ‘Integration only works if data lives in the same system’: How 5 systems are operationalizing behavioral health
- Medicaid work rules and enrollment losses: 6 notes
- Inside UHS’ playbook for responsible behavioral health growth
- Epic4 Specialty Partners adds Illinois practice
- Adventist Health cuts operating loss in 2025
- ‘Burning the candle from both ends’: New York hospital CFO on rising costs, revenue cuts
- The unsolved problems still plaguing dentistry
- American Dental Association adds mental health, GLP-1 prompts to patient forms
- North Carolina orthodontic practice opens 7th location
- Virginia hospital boosts workplace safety reporting 245% with 3 strategic shifts
- ADA urges CMS to proceed with adult dental coverage expansion
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
- Cologuard campaign reunites ‘Full House’ stars to give ‘The Talk’ about colon cancer screening
- Lilly to remove certain insulin products from European markets by 2027
- Karyopharm, looking to jump-start Xpovio, reports mixed results in myelofibrosis
- Study Warns Fluoride Bans May Raise Tooth Decay in Children
- WuXi Bio's record number of new projects in 2025 leaned heavily on US clients
- “Me engañaron”: agentes encadenan a un padre que había ido al ICE a reunirse con sus hijos
- Gilead inks Manta pact to dive deeper into cancer patient support
- Cheap Children's Clothing Tainted With Lead, Study Says
- Insulin Prices Fell For Medicare Patients Under Biden-Era Caps, Study Finds
- New Fathers Face Mental Health Challenges, Study Finds
- Your Choice Of Booze Influences Your Risk Of Death, Study Says
- AI Gets a 'D' When Judging Scientific, Medical Claims
- New Online Tool Helps Parkinson's Patients Weigh Brain Implant Decision
- AI chatbot use for health information up 16% from 2024: Rock Health survey
- ‘They Tricked Me’: A Father Was Chained After He Went to ICE To Reunite With His Kids
- Wilmington PharmaTech commits $50M to US API expansion
- Strides recalls nearly 90K bottles of children's ibuprofen after contamination complaints
- Trump administration unveils national policy framework for AI as it moves to override state laws
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- 17 spine surgery firsts in Q1
- 17 spine surgery firsts in Q1
- Cencora acquiring EyeSouth Partners' retina business for $1.1B
- Aunque tengas seguro dental, la factura puede ser muy alta
- A look at how Optum Rx is using AI to address pharmacy fraud, waste and abuse
- Nursing Homes Accused of False Diagnoses To Hide Drug Use
- FDA Approves Higher-Dose Wegovy To Help People Lose More Weight
- Teens Often Pressured To Send Sexual Photos by Someone They Know, Study Finds
- CommonSpirit, Humana reach 3-year national network agreement
- Match Day 2026: Growth in emergency medicine, psychiatry
- Nearly 90,000 Bottles of Children’s Ibuprofen Recalled Nationwide
- FTC launches multi-bureau Healthcare Task Force to spot 'new priority areas for enforcement'
- Algunos adultos de mediana edad deciden posponer la atención médica hasta tener Medicare
- Rural hospitals could apply for temporary interest-free construction, renovation loans under new bipartisan bill
- Rural Residents Have Highest Cancer Death Rates, Researchers Say
- Your Bank Account Might Show How Well Your Brain Will Age, Researchers Say
- Insurance Lapses Play Havoc With Diabetes Management, Study Shows
- Psychedelics Aren't Better Than Antidepressants In Treating Depression, Review Concludes
- A Nasal Swab for Alzheimer's? Duke Team Has One in Testing
The White House withdrew its nomination of Dr. Dave Weldon, a former Florida congressman, shortly before his scheduled appearance before the Senate Health, Education, Labor and Pensions Committee on Thursday. An anonymous White House official has said that Weldon didn't have the votes needed for confirmation by the Senate. Dr. Weldon wrote a four-page statement which was published by The Washington Post and The New York Times.
Big Pharma and the American Public Health Association were opposed to Dr. Weldon because he brought attention to research linking the MMR vaccine and IBD in children.
Jennifer Galardi of the Epoch Times wrote the most complete post mortem of Dr. Weldon's CDC nomination:
https://thefederalist.com/2025/03/14/scuttled-cdc-pick-slams-big-pharma-and-senators-on-its-payroll/
Scuttled CDC Pick Slams Big Pharma And Senators On Its Payroll
By Jennifer Galardi - March 14, 2025In a statement released on the day of his abruptly canceled confirmation hearing, Dr. Dave Weldon, President Trump’s initial nominee to lead the Centers for Disease Control and Prevention, said concerns that Big Pharma was behind the subversion were “probably true.”
“They are hands-down, the most powerful lobby organization in Washington DC giving millions of dollars to politicians on both sides of the aisle,” he wrote.
Weldon said that Wednesday evening, before the morning of his hearing before the Senate Health, Education, Labor, and Pensions (HELP) committee, he had received a call from a White House assistant telling him his nomination had been withdrawn due to a lack of affirmative votes.
According to Weldon’s statement, Health and Human Services Secretary Robert F. Kennedy Jr. told him Sen. Susan Collins of Maine suddenly “had reservations” about confirming him despite having “a very pleasant meeting” with Weldon previously.
“I can assume that the White House staff had my nomination withdrawn also because the Republican Chairman Dr. Bill Cassidy of Louisiana was also voting no,” Weldon wrote.
His claim that “politicians on both sides of the aisle” receive millions of dollars from pharmaceutical companies and lobbyists is undoubtedly true. Pharmaceutical companies spend almost $300 million on lobbying, far outpacing competitors such as the electronics manufacturing industry and insurance companies.
Why might Big Pharma have an interest in pressuring members of Congress to deny Weldon the job? You don’t have to look very far for the answer. Just review the hearings of every health official Trump has nominated to a cabinet position over the past month or so and count how many times “anti-vax” is said.
As a congressman from Florida 25 years ago, Weldon had the “temerity,” as he said in his letter, to question the pharmaceutical companies on what he called two “critical childhood vaccine safety issues.” Weldon said he, like Kennedy, had been approached by hundreds of parents insisting that vaccines had caused injuries, including autism, to their children. Back then, the concern was over a mercury-based preservative in the vaccines known as thimerosal, which is considered a neurotoxin.
Eventually the CDC and pharmaceutical companies agreed to remove thimerosal, though the preservative is still allowed in small amounts in some flu vaccines. The AI overview that pops up in a Google search claims “Extensive scientific research … has concluded that there is no credible evidence linking thimerosal to autism or other neurodevelopmental disorders.” Could it be because the major scientific and medical bodies were incentivized not to find credible evidence?
Weldon asserted that when the “CDC ended up publishing a research study claiming the mercury had done no harm,” there were “credible accusations that CDC had incorrectly manipulated the data to exonerate themselves.”
Weldon also took on the MMR (measles, mumps, rubella) shot, according to his letter, after coming across research by British pediatric gastroenterologist Andrew Wakefield suggesting that many children had suffered a form of inflammatory bowel disease upon taking the MMR shot.
Wakefield sent samples to Irish virologist John O’Leary, “who was able to show … that the inflammatory bowel disease biopsies in these children contained the vaccine strain measles viruses,” Weldon wrote. The theory was that it “also might have been affecting their central nervous system and causing the autistic features.”
Measles cases rose after parents became hesitant to give their kids the MMR shot, due to Wakefield and O’Leary’s research. Essentially, Weldon concluded, O’Leary was pressured to retract his findings and Wakefield lost his medical license.
Weldon believes these two objections killed his shot at being CDC director. He has forever been tarnished as an “anti-vaxxer” despite his insistence that he just wants solid, unbiased research done on the safety of vaccines.
“I have learned the hard way don’t mess with Pharma,” he wrote.
It raises the question: Can Big Pharma be beaten? Can Kennedy and his cohorts at the multiple health agencies really change the way people view health? The entire medical-industrial complex includes not only pharmaceutical companies, but hospitals, insurance companies, and even large food conglomerates, and it propels a good chunk of the American economy.
According to the Census Bureau’s 2019 American Community Survey (ACS), the healthcare industry employs 22 million workers, or 14 percent of the American workforce. Healthcare employment growth is projected to exceed the national average, even though access to primary care physicians is decreasing, suggesting growth in medical bureaucracy and administration rather than direct care providers.
People seem to forget that sickness is a very lucrative business. Pharmaceutical companies, more than any other industry in the medical establishment, are selling you a product. They pressure you to buy — and doctors to sell — their products through commercials, complete with musical dance numbers.
Pharmaceutical companies spend a lot of money researching why people might be hesitant to inject a vaccine into their body, so they can better shut down those concerns. However, according to a report in The Washington Post last week, the NIH will be terminating or limiting grants to fund research related to vaccine hesitancy. It’s a good first step to undoing the propaganda consistently forced down our throats when it comes to so-called healthcare.
Dave Weldon would have been an excellent choice to continue that trend at the CDC. Let’s hope President Trump will find someone equally courageous to follow in his footsteps — someone who can’t be purchased.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















